854

• 
  Olivier Bylicki, Pascale Tomasini, Gervais Radj, Florian Guisier, Isabelle Monnet, et al.. Atezolizumab with or without bevacizumab and platinum-pemetrexed in patients with stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies: A multicentre phase II open-label non-randomised study GFPC 06-2018. European Journal of Cancer, 2023, 183, pp.38-48. ⟨10.1016/j.ejca.2023.01.014⟩. ⟨hal-04016683⟩
• 
  Rosemary Dubbeldam, Yu Yuan Lee, Juliana Pennone, Luis Mochizuki, Charlotte Le Mouel. Systematic review of candidate prognostic factors for falling in older adults identified from motion analysis of challenging walking tasks. European Review of Aging and Physical Activity, 2023, 20 (1), pp.2. ⟨10.1186/s11556-023-00312-9⟩. ⟨hal-04043074⟩
• 
  Gaëlle Frenois-Veyrat, Franck Gallardo, Olivier Gorgé, Elie Marcheteau, Olivier Ferraris, et al.. Tecovirimat is highly efficient on the Monkeypox virus lineage responsible for the international 2022 outbreak. 2022. ⟨pasteur-04036302⟩
• 
  Rosel Tallach, Sharon Einav, Karim Brohi, Kirthi Abayajeewa, Paer-Sellim Abback, et al.. Learning from terrorist mass casualty incidents: a global survey. British Journal of Anaesthesia, 2022, 128 (2), pp.e168-e179. ⟨10.1016/j.bja.2021.10.003⟩. ⟨hal-04015186⟩
• 
  Daniel Jost, Sabine Lemoine, Frédéric Lemoine, Clément Derkenne, Sébastien Beaume, et al.. Prehospital Lyophilized Plasma Transfusion for Trauma-Induced Coagulopathy in Patients at Risk for Hemorrhagic Shock. JAMA Network Open, 2022, 5 (7), pp.e2223619. ⟨10.1001/jamanetworkopen.2022.23619⟩. ⟨hal-04015192⟩